PBH
PBH
NYSE · Pharmaceuticals

Prestige Consumer Healthcare

$46.05
+0.59 (+1.30%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +69.7% upside
Low Target $50.25
Average Target $78.15
High Target $108.25
Current Price $46.05
Current
$46.05
Target
$78.15
$50.25 $78.15 avg $108.25
Scenario Analysis
Bear Case
$50.25
9.1%
Low target
Base Case
$78.15
+69.7%
Avg target
Bull Case
$108.25
+135.1%
High target
Risk/Reward
14.8x
Highly favorable
Price in Context
52-Week High
$85.29
-46.0% from high
52-Week Low
$42.62
+8.0% from low
50-Day SMA
$64.04
-28.1% vs SMA
200-Day SMA
$69.15
-33.4% vs SMA
RSI (14)
68.6
Neutral
Target vs 52W High
$78.15
-8.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%